Enterome Bioscience SA - Product Pipeline Analysis, 2018 Update

  • ID: 4267296
  • Company Profile
  • 38 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Da Volterra SAS
  • Histalim Sarl
  • Isochem SAS
  • MORE
Summary

Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome-based biomarkers and screen for microbiome-derived molecules. It also develops new diagnostic products for patient classification and forecasting treatment response. Enterome provides microbiome-derived molecules as drug candidates. The company develops drugs for treatment of microbiome-related diseases which include metabolic, inflammatory bowel diseases, and central nervous system linked diseases. Enterome is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Enterome Bioscience SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Da Volterra SAS
  • Histalim Sarl
  • Isochem SAS
  • MORE
Enterome Bioscience SA Company Overview
Enterome Bioscience SA Company Snapshot
Enterome Bioscience SA Pipeline Products and Ongoing Clinical Trials Overview
Enterome Bioscience SA – Pipeline Analysis Overview
Enterome Bioscience SA - Key Facts
Enterome Bioscience SA - Major Products and Services
Enterome Bioscience SA Pipeline Products by Development Stage
Enterome Bioscience SA Pipeline Products Overview
Biomarker Panel - Liver Cirrhosis
Biomarker Panel - Liver Cirrhosis Product Overview
Biomarker Test - Non-Alcoholic Fatty Liver Disease (NAFLD)
Biomarker Test - Non-Alcoholic Fatty Liver Disease (NAFLD) Product Overview
CDx Test (IBD 210) Crohn's Disease- AIEC Carriage
CDx Test (IBD 210) Crohn's Disease- AIEC Carriage Product Overview
Diagnostic Test - Autism
Diagnostic Test - Autism Product Overview
Diagnostic Test - Depression
Diagnostic Test - Depression Product Overview
Diagnostic Test - Multiple Sclerosis
Diagnostic Test - Multiple Sclerosis Product Overview
Diagnostic Test - Parkinson's Disease
Diagnostic Test - Parkinson's Disease Product Overview
Diagnostic Test - Type 2 Diabetes
Diagnostic Test - Type 2 Diabetes Product Overview
Dx test (IBD 110) Crohn's Disease - Activity Monitoring
Dx test (IBD 110) Crohn's Disease - Activity Monitoring Product Overview
EFL Test
EFL Test Product Overview
IBD 120 Ulcerative Collitis Relapse Prediction Test
IBD 120 Ulcerative Collitis Relapse Prediction Test Product Overview
IOC520
IOC520 Product Overview
MET 220 Bariatric Surgery-Outcome Prediction Test
MET 220 Bariatric Surgery-Outcome Prediction Test Product Overview
MET 230 Stratified Nutrition Test
MET 230 Stratified Nutrition Test Product Overview
Non-invasive Monitoring Tool - Cancer
Non-invasive Monitoring Tool - Cancer Product Overview
Enterome Bioscience SA - Key Competitors
Enterome Bioscience SA - Key Employees
Enterome Bioscience SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Enterome Bioscience SA, Recent Developments
Sep 20, 2017: Enterome to Move its Research Laboratories to Genopole, France’s First Biocluster
Jul 12, 2017: Enterome Appoints Mary Thistle to its Board of Directors
Jul 11, 2017: Enterome and Nestle Health Sciences launch new diagnostics company
Dec 09, 2016: Enterome announces management changes
Nov 03, 2016: Enterome Appoints Christophe Bonny as Chief Scientific Officer
May 19, 2016: Enterome Initiates Strategic Expansion With the Opening of US Office in Cambridge, MA
Sep 29, 2015: Georges Gemayel Appointed Non-executive Chairman of Enterome
Mar 19, 2015: Oral Presentation and Poster at the IHMC congress in Luxembourg
Jun 17, 2014: Enterome to participate on panel at BIO2014 entitled: Microbiome Modulators: Opportunities and Challenges to Creating a New Drug Class
Apr 24, 2014: Enterome to Chair Panel at Forthcoming Microbiome / Microbiota R&D and Business Collaboration Forum in London, UK
Appendix
Methodology
About
Contact Us
Disclaimer

List of Tables
Enterome Bioscience SA Pipeline Products and Ongoing Clinical Trials Overview
Enterome Bioscience SA Pipeline Products by Equipment Type
Enterome Bioscience SA Pipeline Products by Indication
Enterome Bioscience SA, Key Facts
Enterome Bioscience SA, Major Products and Services
Enterome Bioscience SA Number of Pipeline Products by Development Stage
Enterome Bioscience SA Pipeline Products Summary by Development Stage
Biomarker Panel - Liver Cirrhosis - Product Status
Biomarker Panel - Liver Cirrhosis - Product Description
Biomarker Test - Non-Alcoholic Fatty Liver Disease (NAFLD) - Product Status
Biomarker Test - Non-Alcoholic Fatty Liver Disease (NAFLD) - Product Description
CDx Test (IBD 210) Crohn's Disease- AIEC Carriage - Product Status
CDx Test (IBD 210) Crohn's Disease- AIEC Carriage - Product Description
Diagnostic Test - Autism - Product Status
Diagnostic Test - Autism - Product Description
Diagnostic Test - Depression - Product Status
Diagnostic Test - Depression - Product Description
Diagnostic Test - Multiple Sclerosis - Product Status
Diagnostic Test - Multiple Sclerosis - Product Description
Diagnostic Test - Parkinson's Disease - Product Status
Diagnostic Test - Parkinson's Disease - Product Description
Diagnostic Test - Type 2 Diabetes - Product Status
Diagnostic Test - Type 2 Diabetes - Product Description
Dx test (IBD 110) Crohn's Disease - Activity Monitoring - Product Status
Dx test (IBD 110) Crohn's Disease - Activity Monitoring - Product Description
EFL Test - Product Status
EFL Test - Product Description
IBD 120 Ulcerative Collitis Relapse Prediction Test - Product Status
IBD 120 Ulcerative Collitis Relapse Prediction Test - Product Description
IOC520 - Product Status
IOC520 - Product Description
MET 220 Bariatric Surgery-Outcome Prediction Test - Product Status
MET 220 Bariatric Surgery-Outcome Prediction Test - Product Description
MET 230 Stratified Nutrition Test - Product Status
MET 230 Stratified Nutrition Test - Product Description
Non-invasive Monitoring Tool - Cancer - Product Status
Non-invasive Monitoring Tool - Cancer - Product Description
Enterome Bioscience SA, Key Employees
Enterome Bioscience SA, Subsidiaries
Glossary

List of Figures
Enterome Bioscience SA Pipeline Products by Equipment Type
Enterome Bioscience SA Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Isochem SAS
  • Histalim Sarl
  • Da Volterra SAS
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll